SGS (SGSN) H1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
H1 2026 earnings summary
24 Jul, 2026Executive summary
Achieved strong H1 2026 results with sales of CHF 3,683 million, 7.6% year-over-year growth, and 5.6% organic growth, despite headwinds from the Middle East crisis.
Margin expansion continued, with adjusted operating income margin improving by 20bps to 15.1% and EPS before HQ disposal rising 14.5%.
Free cash flow reached CHF 260 million, up 25% year-over-year, driven by strong operational performance.
Strategy 27 and a focus on Digital Trust (38% growth) and Sustainability (18% growth) drove performance, supported by ATS integration and 14 bolt-on acquisitions.
Portfolio evolution included the disposal of Maine Pointe and management changes, with a new Head of Europe and Latin America.
Financial highlights
Sales reached CHF 3,683 million, up 7.6% in CHF and 13.4% in constant currency, with 5.6% organic growth and 7.8% from M&A.
Adjusted operating income rose to CHF 555 million, margin at 15.1% (+20bps year-over-year); AOI margin improvement driven by organic and M&A contributions.
EPS before HQ disposal increased 14.5% to CHF 1.58; basic EPS was CHF 1.58, down 3.7% due to prior year HQ disposal gain.
Free cash flow before HQ disposal was CHF 260 million, up 25% year-over-year.
Net debt increased to CHF 3,916 million, mainly due to acquisitions and dividend payments.
Outlook and guidance
2026 outlook confirmed: 5–7% organic sales growth, 5–7% additional sales from acquisitions, AOI margin ≥16%, and >50% cash conversion.
2027 objectives reaffirmed: annual organic sales growth of 5–7%, at least 1.5pp AOI margin improvement vs. 2023, cash conversion >50%.
Strong exit rates in Q2 for organic growth and margins expected to continue into H2.
Capital Markets Event scheduled for 17–18 November 2026.
Latest events from SGS
- Strategy 2030 pairs 5%–7% organic growth with ≥17% margin and AI-led leverage.SGSN
CMD 2026 Part 2 - Strategy 2030 targets 6–9% annual growth and at least 17% adjusted margin by 2030.SGSN
CMD 2026 Part 1 - Record Q3 sales combined 5.7% organic growth with 6.9% scope gains.SGSN
Q3 2026 TU - Record Q1 2026 sales and strong organic growth reaffirm robust 2026 outlook.SGSN
Q1 2026 TU - Record sales, margin gains, and strong cash flow set up a positive 2026 outlook.SGSN
H2 2025 - Strategy 27 targets CHF 800m+ new sales, doubled North America revenue, and ESG leadership by 2027.SGSN
Investor Day 2024 Day 2(CEO Plenary) - Q3 organic sales up 7.3%, driven by sustainability, PFAS, and bolt-on acquisitions.SGSN
Q3 2024 TU - 8.0% organic growth, stable margins, and strong cash flow highlight robust H1 2024.SGSN
H1 2024 - Record sales, margin expansion, and strong cash flow highlight robust 2024 performance.SGSN
H2 2024